Correction: Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design.
作者信息
Daamen L A, van Goor I W J M, Groot V P, Andel P C M, Brosens L A A, Busch O R, Cirkel G A, Mohammad N Haj, Heerkens H D, de Hingh I H J T, Hoogwater F, van Laarhoven H W M, Los M, Meijer G J, de Meijer V E, Pande R, Roberts K J, Stoker J, Stommel M W J, van Tienhoven G, Verdonk R C, Verkooijen H M, Wessels F J, Wilmink J W, Besselink M G, van Santvoort H C, Intven M P W, Molenaar I Q
机构信息
Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center & St. Antonius Hospital Nieuwegein, Nieuwegein, the Netherlands.
Division of Imaging, UMC Utrecht Cancer Center, Utrecht University, Utrecht, the Netherlands.
出版信息
Trials. 2024 Jul 5;25(1):456. doi: 10.1186/s13063-024-08295-3.
Abstract
摘要
相似文献
1
Correction: Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design.更正：使用以复发为重点的监测策略（RADAR-PANC）在胰腺导管腺癌切除术后检测复发性疾病：根据队列内试验设计的一项国际随机对照试验方案。
Trials. 2024 Jul 5;25(1):456. doi: 10.1186/s13063-024-08295-3.
2
Minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma (DIPLOMA): study protocol for a randomized controlled trial.微创与开腹胰体尾切除术治疗胰腺导管腺癌（DIPLOMA）：一项随机对照试验的研究方案。
Trials. 2021 Sep 9;22(1):608. doi: 10.1186/s13063-021-05506-z.
3
MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma.MAPLE-PD试验（胰十二指肠切除术中胰腺癌的肠系膜入路与传统入路对比）：一项针对354例胰腺导管腺癌患者的多中心随机对照试验的研究方案
Trials. 2018 Nov 8;19(1):613. doi: 10.1186/s13063-018-3002-z.
4
PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer.PIONEER-Panc：一项针对局部胰腺癌新出现治疗方法的 II 期随机研究的平台试验。
BMC Cancer. 2022 Jan 3;22(1):14. doi: 10.1186/s12885-021-09095-7.
5
Unresectable pancreatic ductal adenocarcinoma in the remnant pancreas diagnosed during every-6-month surveillance after resection of branch duct intraductal papillary mucinous neoplasm: a case report.分支导管内乳头状黏液性肿瘤切除术后每6个月监测时诊断出的残余胰腺不可切除性胰腺导管腺癌：一例报告
JOP. 2013 Jul 10;14(4):450-3. doi: 10.6092/1590-8577/1494.
6
Optimal surveillance of intraductal papillary mucinous neoplasms of the pancreas focusing on remnant pancreas recurrence after surgical resection.胰腺导管内乳头状黏液性肿瘤的最佳监测：聚焦于手术后残胰腺复发。
BMC Cancer. 2022 May 29;22(1):588. doi: 10.1186/s12885-022-09650-w.
7
Risk factors for early recurrence in patients with pancreatic ductal adenocarcinoma who underwent curative resection.胰导管腺癌患者根治性切除术后早期复发的危险因素。
World J Surg Oncol. 2023 Aug 24;21(1):263. doi: 10.1186/s12957-023-03141-3.
8
Surgical resection for liver recurrence after curative resection of pancreatic ductal adenocarcinoma.胰导管腺癌根治性切除术后肝复发的外科切除。
Langenbecks Arch Surg. 2023 Jul 17;408(1):280. doi: 10.1007/s00423-023-03009-w.
9
CYP2J2produced epoxyeicosatrienoic acids contribute to the ferroptosis resistance of pancreatic ductal adenocarcinoma in a PPARdependent manner.CYP2J2 产生的环氧二十碳三烯酸以依赖 PPAR 的方式促进胰腺导管腺癌的铁死亡抵抗。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021;46(9):932-941. doi: 10.11817/j.issn.1672-7347.2021.210413.
10
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.新辅助FOLFIRINOX方案与直接手术治疗可切除胰头癌的比较（NORPACT-1）：一项多中心、随机、2期试验
Lancet Gastroenterol Hepatol. 2024 Mar;9(3):205-217. doi: 10.1016/S2468-1253(23)00405-3. Epub 2024 Jan 15.
本文引用的文献
1
Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design.使用基于复发监测策略的 RADAR-PANC 对胰腺导管腺癌切除术后的疾病复发进行检测：一项按照队列内试验设计的国际随机对照试验方案。
Trials. 2024 Jun 20;25(1):401. doi: 10.1186/s13063-024-08223-5.
Zotero 插件